Literature DB >> 3955324

Pseudodementia: facts and figures.

A Bulbena, G E Berrios.   

Abstract

The historical and conceptual aspects of the pseudodementia state are briefly touched upon. A "collective sample", composed of 61 cases culled from the literature, is analysed and compared with the "Fulbourn sample" consisting of 22 cases reported for the first time. Two sub-types of pseudodementia emerge, one associated with depressive illness and the other with delirium. A follow-up of the Fulbourn sample (1-4 years after discharge) showed 14 patients to be alive and 8 to show no signs of dementia. No variable except the diagnosis "non-specific psychosis" correlated with death during the follow-up period.

Entities:  

Mesh:

Year:  1986        PMID: 3955324     DOI: 10.1192/bjp.148.1.87

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  5 in total

Review 1.  Major depressive disorder with psychotic features may lead to misdiagnosis of dementia: a case report and review of the literature.

Authors:  Gerhardt S Wagner; Shawn M McClintock; Peter B Rosenquist; W Vaughn McCall; David A Kahn
Journal:  J Psychiatr Pract       Date:  2011-11       Impact factor: 1.325

Review 2.  Pseudodementia: a slow death.

Authors:  P D Nussbaum
Journal:  Neuropsychol Rev       Date:  1994-06       Impact factor: 7.444

3.  Weight Rich-Club Analysis in the White Matter Network of Late-Life Depression with Memory Deficits.

Authors:  Naikeng Mai; Xiaomei Zhong; Ben Chen; Qi Peng; Zhangying Wu; Weiru Zhang; Cong Ouyang; Yuping Ning
Journal:  Front Aging Neurosci       Date:  2017-08-23       Impact factor: 5.750

4.  Pseudodementia, pseudo-pseudodementia, and pseudodepression.

Authors:  Henry Brodaty; Michael H Connors
Journal:  Alzheimers Dement (Amst)       Date:  2020-04-19

Review 5.  Cognitive impairment in depression: recent advances and novel treatments.

Authors:  Giulia Perini; Matteo Cotta Ramusino; Elena Sinforiani; Sara Bernini; Roberto Petrachi; Alfredo Costa
Journal:  Neuropsychiatr Dis Treat       Date:  2019-05-10       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.